Trials / Completed
CompletedNCT05376930
Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
A Multi-center, Open-label, Extension Study to Evaluate the Long-term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is evaluate the long term safety and efficacy of DWP16001 compared to placebo in the treatment of type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP16001 Amg | DWP16001 Amg, Tablets, Orally, Once daily |
Timeline
- Start date
- 2021-09-16
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2022-05-17
- Last updated
- 2022-10-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05376930. Inclusion in this directory is not an endorsement.